Email ID
Password
Scrip   
Face-to-face: EyeGate looks beyond iontophoresis dry eye trial
03 June 2009
Nancy Faigen

Stephen From, president and CEO of EyeGate Pharma, has pointed to the need for a clear alternative to invasive ocular delivery methods for ophthalmic medicines, and has explained how EyeGate is advancing the role of iontophoresis.

...



Please Login to read the full article.
JOB OF THE WEEK Promote your vacancy here
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36